Grifols SA logo

Grifols SA

GIFLF · OTC · Health Technology, Pharmaceuticals: Major · Founded 1909

Grifols SA is a global specialty plasma therapeutics company that engages in the development, manufacturing, and distribution of a broad range of biological medicines based on plasma-derived proteins. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others.

Current Price
$12.24
Market Cap
$7.3B
Return Since Last Split
-42%
Last Split
Jan 4, 2016
Total Splits
1
Cumulative Multiple
2×

What If You Bought GIFLF Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$2,448
200 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth within the displayed company lineage.

Split DatePrice BeforeRatioSplit MultipleCumulative
Jan 4, 2016$23.082-for-12×2×

Grifols SA Market Cap Timeline

A validated annual market-cap history is unavailable from the current sources. The current market-cap snapshot, when shown above, is not treated as historical evidence. Split markers cover 1 current-security split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Validated annual history unavailable

At least two source-validated annual observations are required before this page draws a market-cap timeline. A current snapshot is not treated as historical trend data.

Recorded split dates

Frequently Asked Questions

Grifols SA's latest record in the split calendar is a 2-for-1 forward split effective 2016-01-04.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.